University of Maryland School of Medicine Appoints Gerald M. Wilson as Chair of Biochemistry and Molecular Biology Department
On December 15, 2025, the University of Maryland School of Medicine (UMSOM) announced a significant leadership change within its academic ranks, appointing Dr. Gerald M. Wilson as the Chair of the Department of Biochemistry and Molecular Biology. This appointment marks a pivotal moment for the department, which is now under the stewardship of a scientist with over two decades of pertinent experience and internationally acclaimed research in the field of RNA biochemistry and its connections to cancer mechanisms.
Dr. Wilson, who has been affiliated with the UMSOM since 2002, has ascended through various academic ranks—from Assistant Professor to Professor, achieving tenure in 2009 and further solidifying his role by becoming a prominent figure in the department. His tenure has been characterized by a deep commitment to mentoring and educational innovation, directing the UMB/UMBC Graduate Program in Biochemistry and Molecular Biology from 2011 to 2023, where he prepared the next generation of leaders in the biomedical field. During this time, he also served as the Interim Chair for the past two years, providing steady leadership during a phase of transition within the department.
As Dr. Wilson steps into this new role, he inherits not just the title but a vision to enhance the research capabilities of the department. His scholarly contributions highlight his depth of knowledge; with over 80 peer-reviewed publications and an impressive h-index of 42, his research has substantially contributed to understanding the complexities of RNA-protein interactions, emphasizing post-transcriptional gene regulation and its implications in both cancer and cardiovascular diseases. His achievements in the field have attracted major funding from prestigious organizations such as the National Institutes of Health (NIH) and the American Cancer Society.
Additionally, Dr. Wilson is recognized for his innovative contributions to cancer research, including his co-editorship of the recent book "RNA-Based Mechanisms in Cancer" and multiple U.S. patents for pioneering DNA ligase inhibitors intended for cancer therapy. Such accomplishments underscore his commitment to not only research but also the practical application of scientific findings in healthcare improvements.
Dean Mark T. Gladwin, MD, commended Dr. Wilson for his ability to enhance departmental coherence and creativity in research through his engagement. "I have no doubt that Gerald will continue to drive the department toward revitalization in drug discovery, improve core facilities and research spaces, and recruit exceptional faculty through collaborations with the UM Greenebaum Comprehensive Cancer Center and the Division of Cardiovascular Medicine," Dean Gladwin stated.
As Chair, Dr. Wilson intends to uphold a culture of inclusivity, resource stewardship, and educational innovation, while also promoting academic citizenship. His leadership approach aims to strengthen the capabilities of the department, ensuring scientific advancements translate into tangible healthcare benefits, a pursuit that is critical in today’s evolving medical landscape.
Dr. Wilson's academic journey began with a Bachelor of Science and a PhD in Biochemistry from Queen's University in Kingston, Canada, followed by postdoctoral training at Wake Forest University and the University of Medicine and Dentistry of New Jersey. His extensive background in the field positions him well to guide the department through its next chapter.
With his appointment, the University of Maryland School of Medicine is poised to enhance its research and educational profiles, ultimately impacting healthcare outcomes in the community and beyond. The collaboration of skilled scholars under his leadership is anticipated to usher in new breakthroughs in biomedical research, reaffirming the university’s commitment to excellence in medical science.
Dr. Wilson, who has been affiliated with the UMSOM since 2002, has ascended through various academic ranks—from Assistant Professor to Professor, achieving tenure in 2009 and further solidifying his role by becoming a prominent figure in the department. His tenure has been characterized by a deep commitment to mentoring and educational innovation, directing the UMB/UMBC Graduate Program in Biochemistry and Molecular Biology from 2011 to 2023, where he prepared the next generation of leaders in the biomedical field. During this time, he also served as the Interim Chair for the past two years, providing steady leadership during a phase of transition within the department.
As Dr. Wilson steps into this new role, he inherits not just the title but a vision to enhance the research capabilities of the department. His scholarly contributions highlight his depth of knowledge; with over 80 peer-reviewed publications and an impressive h-index of 42, his research has substantially contributed to understanding the complexities of RNA-protein interactions, emphasizing post-transcriptional gene regulation and its implications in both cancer and cardiovascular diseases. His achievements in the field have attracted major funding from prestigious organizations such as the National Institutes of Health (NIH) and the American Cancer Society.
Additionally, Dr. Wilson is recognized for his innovative contributions to cancer research, including his co-editorship of the recent book "RNA-Based Mechanisms in Cancer" and multiple U.S. patents for pioneering DNA ligase inhibitors intended for cancer therapy. Such accomplishments underscore his commitment to not only research but also the practical application of scientific findings in healthcare improvements.
Dean Mark T. Gladwin, MD, commended Dr. Wilson for his ability to enhance departmental coherence and creativity in research through his engagement. "I have no doubt that Gerald will continue to drive the department toward revitalization in drug discovery, improve core facilities and research spaces, and recruit exceptional faculty through collaborations with the UM Greenebaum Comprehensive Cancer Center and the Division of Cardiovascular Medicine," Dean Gladwin stated.
As Chair, Dr. Wilson intends to uphold a culture of inclusivity, resource stewardship, and educational innovation, while also promoting academic citizenship. His leadership approach aims to strengthen the capabilities of the department, ensuring scientific advancements translate into tangible healthcare benefits, a pursuit that is critical in today’s evolving medical landscape.
Dr. Wilson's academic journey began with a Bachelor of Science and a PhD in Biochemistry from Queen's University in Kingston, Canada, followed by postdoctoral training at Wake Forest University and the University of Medicine and Dentistry of New Jersey. His extensive background in the field positions him well to guide the department through its next chapter.
With his appointment, the University of Maryland School of Medicine is poised to enhance its research and educational profiles, ultimately impacting healthcare outcomes in the community and beyond. The collaboration of skilled scholars under his leadership is anticipated to usher in new breakthroughs in biomedical research, reaffirming the university’s commitment to excellence in medical science.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.